More than 135 abstracts accepted for presentation across all phases of drug development

Dr. Ishwaria Subbiah to lead new programs focused on patient and clinical workplace experiences

Dr. Vivek Subbiah to serve as chief, early-phase drug development across SCRI's Research Network

SCRI and Mirati today announced a strategic partnership aimed at increasing diversity in clinical study recruitment practices.